Encoded Therapeutics

Encoded Therapeutics

CA - South SF
Biotechnology

Focus: Gene Therapy

Encoded Therapeutics is a life sciences company focused on Gene Therapy.

Gene Therapy
Funding Stage
PUBLIC
Open Jobs
4

Pipeline & Clinical Trials

Transcranial Magnetic Stimulation
Dravet Syndrome
N/A
Clinical Trials (1)
NCT04614506Transcranial Magnetic Stimulation to Measure Cortical Excitability in Dravet Syndrome
N/A
Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SC
Dravet Syndrome
N/A
Clinical Trials (1)
NCT07251673Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
N/A
No Intervention
Dravet Syndrome
N/A
Clinical Trials (1)
NCT04537832Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies
N/A
GABA Blood Level
Dravet Syndrome
N/A
Clinical Trials (1)
NCT05651204GABA Biomarkers in Dravet Syndrome
N/A
Phase 1/2
Clinical Trials (1)
NCT06283212A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT05419492A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT06112275A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome (Australia Only)
Phase 1/2

Open Jobs (4)

Interview Prep Quick Facts
Founded: 2000
Portfolio: 7 clinical trials
Publications: 13 in PubMed
Open Roles: 4 active jobs